Patterns of cytokine release syndrome with teclistamab in relapsed/refractory multiple myeloma with or without prior T-cell redirection therapy

被引：0

作者：

Hamadeh, Issam ^{[1
]}

Shekarkhand, Tala ^{[1
]}

Rueda, Colin ^{[1
]}

Firestone, Ross ^{[1
]}

Wang, Alice ^{[1
]}

Korde, Neha ^{[1
]}

Hultcrantz, Malin ^{[1
]}

Lesokhin, Alexander ^{[1
]}

Mailankody, Sham ^{[1
]}

Hassoun, Hani ^{[1
]}

Shah, Urvi ^{[1
]}

Maclachlan, Kylee ^{[1
]}

Patel, Dhwani ^{[1
]}

Shah, Gunjan ^{[1
]}

Scordo, Michael ^{[1
]}

Lahoud, Oscar ^{[1
]}

Chung, David ^{[1
]}

Landau, Heather ^{[1
]}

Giralt, Sergio ^{[1
]}

Usmani, Saad ^{[1
]}

Tan, Carlyn Rose ^{[1
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P-013

引用

页码：S40 / S40

页数：1

共 50 条

[41] A Systematic Meta-Analysis of Cytokine Release Syndrome Incidence in B-Cell Maturation Antigen-Targeting Chimeric Antigen Receptor T-Cell Therapy and Bispecific Antibodies for Patients with Relapsed and/or Refractory Multiple Myeloma
Sharma, Sheena
Wang, Diane
Lon, Hoi-Kei
Soltantabar, Pooneh
Viqueira, Andrea
Czibere, Akos
Hickman, Anne
White, Jane Liang
Elmeliegy, Mohamed
BLOOD, 2022, 140 : 10036 - 10038
[42] CAR-T cell therapy in relapsed or refractory multiple myeloma and access in Turkey
Hakan, Goker
Engin, Kelkitli
Elifcan, Karakulak Aladag
Haluk, Demiroglu
Mehmet, Turgut
Suman, Kambhampati
Maxwell, Krem
FRONTIERS IN MEDICINE, 2024, 11
[43] Cytokine Release Syndrome and Neurotoxicity after Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory B-Cell Lymphoma: Is There an Association with Bridging Radiotherapy?
Yegya-Raman, N.
Wright, C. M.
Zhang, S.
Baron, J.
LaRiviere, M. J.
Gerson, J. N.
Nasta, S. D.
Barta, S.
Chong, E. A.
Landsburg, D. J.
Svoboda, J.
Schuster, S.
Xiao, Y.
Maity, A.
Paydar, I.
Plastaras, J. P.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S84 - S85
[44] T-cell phenotypes associated with effective CAR T-cell therapy in postinduction vs relapsed multiple myeloma
Garfall, Alfred L.
Dancy, Ehren K.
Cohen, Adam D.
Hwang, Wei-Ting
Fraietta, Joseph A.
Davis, Megan M.
Levine, Bruce L.
Siegel, Don L.
Stadtmauer, Edward A.
Vogl, Dan T.
Waxman, Adam
Rapoport, Aaron P.
Milone, Michael C.
June, Carl H.
Melenhorst, J. Joseph
BLOOD ADVANCES, 2019, 3 (19) : 2812 - 2815
[45] Prophylactic tocilizumab reduces the incidence of cytokine release syndrome in relapsed/refractory myeloma patients treated with teclistamab: Implications for outpatient step-up dosing
Korst, Charlotte L. B. M.
Groen, Kaz
Bosman, Patricia W. C.
van der Valk, Fleur
Verkleij, Christie P. M.
Kruyswijk, Sandy
de Ruijter, Maaike E. M.
Heijink, Dianne M.
Kuipers, Maria T.
Zweegman, Sonja
van de Donk, Niels W. C. J.
HEMASPHERE, 2024, 8 (07):
[46] Evaluating the efficacy of commercial teclistamab in relapsed refractory multiple myeloma patients with prior exposure to anti-BCMA therapies
Firestone, Ross
Shekarkhand, Tala
Patel, Dhwani
Tan, Carlyn Rose Co
Hultcrantz, Malin
Lesokhin, Alexander M.
Mailankody, Sham
Hassoun, Hani
Shah, Urvi A.
Korde, Neha
Maclachlan, Kylee
Landau, Heather Jolie
Scordo, Michael
Chung, David J.
Shah, Gunjan L.
Lahoud, Oscar Boutros
Giralt, Sergio
Usmani, Saad Zafar
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[47] Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myeloma
Zhou, Dian
Wang, Ying
Cheng, Hai
Zhu, Lili
Chen, Wei
Li, Hujun
Zhang, Xiaotian
Xia, Jieyun
Qi, Yuekun
Ma, Sha
Zhu, Feng
Yan, Zhiling
Qi, Kunming
Sang, Wei
Sun, Haiying
Li, Depeng
Cao, Jiang
Li, Zhenyu
Xu, Kailin
JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (02) : 179 - 185
[48] A Comparison of Standard of Care Idecabtagene Vicleucel and Ciltacabtagene Autoleucel CAR T-cell Therapy in Relapsed or Refractory Multiple Myeloma
Hansen, Doris
Peres, Lauren
Dima, Danai
Richards, Alicia
Shune, Leyla
Afrough, Aimaz
Midha, Shonali
Dhakal, Binod
Kocoglu, Mehmet H.
Ferreri, Christopher
Davis, James
Herr, Megan
Forsberg, Peter
Janakiram, Murali
Reshef, Ran
Sborov, Douglas W.
Khouri, Jack
Richard, Shambavi
Martin, Thomas
Lin, Yi
Patel, Krina
Sidana, Surbhi
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S5 - S5
[49] Vitamin D deficiency and clinical outcomes with chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma
Nishimura, Noriko
Flynn, Jessica
Costa, Bruno
Devlin, Sean
Farzana, Tasmin
Chung, David
Landau, Heather
Lahoud, Oscar
Scordo, Michael
Shah, Gunjan
Hassoun, Hani
Maclachlan, Kylee
Hultcrantz, Malin
Korde, Neha
Lesokhin, Alexander
Shah, Urvi
Tan, Carlyn Rose
Giralt, Sergio
Usmani, Saad
Mailankody, Sham
Nath, Karthik
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S55 - S56
[50] Immunoglobulin isotype switch after anti-BCMA CAR T-cell therapy for relapsed or refractory multiple myeloma
Liang, Zhiyu
Li, Ping
Kang, Liqing
Zhou, Lili
Xu, Yang
Ye, Shiguang
Du, Juan
Li, Bing
Wang, Yiwen
Yu, Lei
Qian, Wenbin
Liang, Aibin
BLOOD ADVANCES, 2022, 6 (01) : 293 - 296

← 1 2 3 4 5 →